URGENT COMMS: Supply Issue affecting Cisplatin 50mg/50ml and 100mg/100ml concentrate for solution for infusion vials

Dear BOPA Pharmacy members

Hopefully, you will have received the enclosed Medicines Supply Notice last week, and the email sent to chief pharmacists yesterday (below).
This email is requesting you take urgent action.

Action: Trusts need to place orders for unlicensed imports of cisplatin NOW.

The lead time is around 2 weeks (but can vary).
As explained below, if Trusts do not place orders, the stock that is being identified by importers is going elsewhere.
Without orders, importers may not be able to identify sufficient quantities and deliver in time.

https://www.bopa.org.uk/resources/msn-2023-066-cisplatin-50mg-in-50ml-and-100mg-in-100ml-concentrate-for-solution-for-infusion-vials/

Best wishes
Raj

Ms Raj Nijjar
Lead Clinical Cancer Pharmacist, Barts Health NHS Trust
& Deputy National Lead Cancer Pharmacist, NHS England

Contact details:
Barts Health NHS Trust (usually Mons & Tues):
Pharmacy Chemotherapy Unit, 7th Floor King George V Wing,
St Bartholomew’s Hospital
West Smithfield, London, EC1A 7BE
Internal: (15) 57055
External: 020 346 57055
Fax: 020 346 56735
Mobile: TBC
e-mail: [email protected]

Latest News

By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article
By Suriya Marshall on 14th March 2026

Clinical Pharmacy Congress. 8th-9th May 2026

Dear BOPA member, We are excited to announce that we have partnered with Clinical Pharmacy Congress 2026. Clinical Pharmacy Congress is the UK’s leading event for clinical pharmacy professionals working across…

Read article
By BOPA Executive Committee on 13th March 2026

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster

London, 10 March 2026: The Safer Healthcare and Biosafety Network (SHBN) launches a new campaign titled “Protecting Healthcare Workers: Safer Handling of Hazardous Medicinal Products” to raise awareness of the dangers…

Read article
By BOPA on 13th March 2026

Invitation to Participate: SWEET-PLUS Study

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article